Trial Profile
A Multicenter, Parallel, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Moderate to Severe Plaque Psoriasis
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Wyeth
- 03 Apr 2022 This trial has been completed in Netherland (End Date: 07 May 2007), according to European Clinical Trials Database record.
- 03 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database record. (End date:2007-05-07)
- 01 Jun 2011 New trial record